Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation. 2024 Laboratoř nádorové imunologieKovář M.Šubr V.Běhalová K.Studenovský M.Starenko D.Kovářová J.Procházková P.Etrych T.Kostka L.Nanomedicine: Nanotechnology; Biology and Medicine. 2024; 56(February 2024); 10273010.1016/j.nano.2023.102730
Metastatic spread inhibition of cancer cells through stimuli-sensitive HPMA copolymer-bound actinonin nanomedicines 2022 Laboratoř nádorové imunologieKousalová J.Šírová M.Kostka L.Šubr V.Kovářová J.Běhalová K.Studenovský M.Kovář M.Etrych T.Nanomedicine: Nanotechnology; Biology and Medicine. 2022; 44(August); 10257810.1016/j.nano.2022.102578
